Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.

Urrego T, Ortiz-Reyes B, Vanegas-García AL, Muñoz CH, González LA, Vásquez G, Gómez-Puerta JA

Open source

DOI
10.1016/j.reuma.2018.02.002
Published
2020 Jan-Feb
Container
Reumatologia clinica
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.reuma.2018.02.002,
  title = {Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.},
  author = {Urrego T and Ortiz-Reyes B and Vanegas-García AL and Muñoz CH and González LA and Vásquez G and Gómez-Puerta JA},
  year = {2020},
  journal = {Reumatologia clinica},
  doi = {10.1016/j.reuma.2018.02.002},
  url = {https://doi.org/10.1016/j.reuma.2018.02.002}
}

RIS

TY  - JOUR
TI  - Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
AU  - Urrego T
AU  - Ortiz-Reyes B
AU  - Vanegas-García AL
AU  - Muñoz CH
AU  - González LA
AU  - Vásquez G
AU  - Gómez-Puerta JA
PY  - 2020
JO  - Reumatologia clinica
DO  - 10.1016/j.reuma.2018.02.002
UR  - https://doi.org/10.1016/j.reuma.2018.02.002
ER  - 

APA

T, U., B, O., AL, V., CH, M., LA, G., G, V., & JA, G. (2020). Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.. Reumatologia clinica. https://doi.org/10.1016/j.reuma.2018.02.002

Source records